Tag Archives: : sex and gender bias in biomedical research

When sex matters

when sex matters

“Women have to know that many of the medications they are taking were identified and the dosages defined based on studies on male animals or men. And it’s well known that women metabolize some drugs differently, their size is different and even the underlying causes of the diseases might be different. Does that mean the medication is bad? No, it means that we need to define the population for which the medication provides the most benefit with the least risk at a reasonable cost”, says Virginia Miller, professor of physiology and surgery at the Mayo Clinic in Rochester, MN, USA and president of the Organization for the Study of Sex Differences (OSSD), an international society for basic and clinical scientists.

The first time I have ever heard about sex-gender bias in biomedical research and gender medicine, some months ago while reading the Science magazine, my first thought was how come I had never wondered how it was possible that drug prescription have the same dosages for me, not even 1,60 meters tall, and let’ say for my Dutch 1,90 meters tall male friend if it’s so obvious we are different. And, as I do every time I find out something new and interesting to me, I started guessing that maybe I wasn’t the only one ignoring the issue and its causes. So I started researching the topic.

Continue reading